103 related articles for article (PubMed ID: 18310272)
1. The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer.
Murphy TM; Perry AS; Lawler M
Endocr Relat Cancer; 2008 Mar; 15(1):11-25. PubMed ID: 18310272
[TBL] [Abstract][Full Text] [Related]
2. Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer.
Carvalho JR; Filipe L; Costa VL; Ribeiro FR; Martins AT; Teixeira MR; Jerónimo C; Henrique R
Apoptosis; 2010 Aug; 15(8):956-65. PubMed ID: 20464497
[TBL] [Abstract][Full Text] [Related]
3. In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer.
Murphy TM; Sullivan L; Lane C; O'Connor L; Barrett C; Hollywood D; Lynch T; Lawler M; Perry AS
Prostate; 2011 Jan; 71(1):1-17. PubMed ID: 20564325
[TBL] [Abstract][Full Text] [Related]
4. The emerging roles of DNA methylation in the clinical management of prostate cancer.
Perry AS; Foley R; Woodson K; Lawler M
Endocr Relat Cancer; 2006 Jun; 13(2):357-77. PubMed ID: 16728568
[TBL] [Abstract][Full Text] [Related]
5. Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer.
Suzuki M; Shigematsu H; Shivapurkar N; Reddy J; Miyajima K; Takahashi T; Gazdar AF; Frenkel EP
Cancer Lett; 2006 Oct; 242(2):222-30. PubMed ID: 16458425
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation and apoptosis.
Gopisetty G; Ramachandran K; Singal R
Mol Immunol; 2006 Apr; 43(11):1729-40. PubMed ID: 16500705
[TBL] [Abstract][Full Text] [Related]
7. HRK inactivation associated with promoter methylation and LOH in prostate cancer.
Higuchi T; Nakamura M; Shimada K; Ishida E; Hirao K; Konishi N
Prostate; 2008 Jan; 68(1):105-13. PubMed ID: 18008329
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.
Meiers I; Shanks JH; Bostwick DG
Pathology; 2007 Jun; 39(3):299-304. PubMed ID: 17558856
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic mechanisms in the biology of prostate cancer.
Schulz WA; Hoffmann MJ
Semin Cancer Biol; 2009 Jun; 19(3):172-80. PubMed ID: 19429481
[TBL] [Abstract][Full Text] [Related]
11. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness.
Yaqinuddin A; Qureshi SA; Qazi R; Farooq S; Abbas F
J Urol; 2009 Aug; 182(2):756-61. PubMed ID: 19539327
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.
Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F
J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943
[TBL] [Abstract][Full Text] [Related]
13. [DNA methylation and prostate cancer].
Zhou SG; Sun YH; Gao JP
Zhonghua Nan Ke Xue; 2007 Dec; 13(12):1108-12. PubMed ID: 18284062
[TBL] [Abstract][Full Text] [Related]
14. [Role of RASSF1A hypermethylation in prostate cancer].
Wang YC; Yu ZH; Chen LB
Zhonghua Nan Ke Xue; 2007 Sep; 13(9):822-5. PubMed ID: 17929562
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of prostate cancer cell survival after inhibition of AR expression.
Cohen MB; Rokhlin OW
J Cell Biochem; 2009 Feb; 106(3):363-71. PubMed ID: 19115258
[TBL] [Abstract][Full Text] [Related]
16. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
17. The role of HRK gene in human cancer.
Nakamura M; Shimada K; Konishi N
Oncogene; 2008 Dec; 27 Suppl 1():S105-13. PubMed ID: 19641496
[TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
[TBL] [Abstract][Full Text] [Related]
19. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients.
Bryzgunova OE; Morozkin ES; Yarmoschuk SV; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():222-5. PubMed ID: 18837951
[TBL] [Abstract][Full Text] [Related]
20. Reprimo as a potential biomarker for early detection in gastric cancer.
Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]